124 related articles for article (PubMed ID: 6549369)
1. The NIH Consensus Report on "Precursors to Malignant Melanoma". A different perspective.
Lynch HT; Fusaro RM; Lynch JF
Am J Dermatopathol; 1984; 6 Suppl():177-9. PubMed ID: 6549369
[No Abstract] [Full Text] [Related]
2. NIH consensus panel report: Precursors to malignant melanoma.
Md State Med J; 1984 Jul; 33(7):532-5. PubMed ID: 6547989
[No Abstract] [Full Text] [Related]
3. From the National Institutes of Health. Precursors to malignant melanoma.
Am J Dermatopathol; 1984; 6 Suppl():169-74. PubMed ID: 6549368
[No Abstract] [Full Text] [Related]
4. Precursors to malignant melanoma.
Natl Inst Health Consens Dev Conf Summ (1980); 1984; 4(9):6 p.. PubMed ID: 6400696
[No Abstract] [Full Text] [Related]
5. Precursors to malignant melanoma. National Institutes of Health Consensus Development Conference Statement, Oct. 24-26, 1983.
J Am Acad Dermatol; 1984 Apr; 10(4):683-8. PubMed ID: 6715623
[No Abstract] [Full Text] [Related]
6. Precursors to malignant melanoma.
Am Fam Physician; 1984 Sep; 30(3):114. PubMed ID: 6475698
[No Abstract] [Full Text] [Related]
7. Precursors to malignant melanoma. National Institutes of Health Consensus Development summary.
Conn Med; 1985 Jan; 49(1):22-5. PubMed ID: 3971709
[No Abstract] [Full Text] [Related]
8. [Malignant melanoma and its precursors (author's transl)].
Mishima Y
Nihon Hifuka Gakkai Zasshi; 1979 Nov; 89(13):928-35. PubMed ID: 317311
[No Abstract] [Full Text] [Related]
9. Re: Sun exposure and mortality from melanoma.
Dellavalle RP; Johnson KR
J Natl Cancer Inst; 2005 Aug; 97(15):1158-9; author reply 1159-60. PubMed ID: 16077075
[No Abstract] [Full Text] [Related]
10. [Classification and nomenclature of malignant melanomas of the skin].
Schmoeckel C
Dtsch Med Wochenschr; 1983 Feb; 108(6):231-2. PubMed ID: 6825599
[No Abstract] [Full Text] [Related]
11. [Etiopathogenesis of malignant melanoma].
Pawińska M; Kik A
Przegl Dermatol; 1980; 67(6):805-9. PubMed ID: 7017815
[No Abstract] [Full Text] [Related]
12. [Etiology of malignant melanoma--what do we know?].
Helsing P
Tidsskr Nor Laegeforen; 1997 Mar; 117(7):969-71. PubMed ID: 9103011
[TBL] [Abstract][Full Text] [Related]
13. National Institutes of Health consensus report on precursors to malignant melanoma. A difference in opinion.
Lynch HT; Fusaro RM
JAMA; 1984 Nov 23-30; 252(20):2872-3. PubMed ID: 6492369
[No Abstract] [Full Text] [Related]
14. The role of atypical mole syndrome and cutaneous naevi in the development of melanoma.
Easton D
Cancer Surv; 1996; 26():237-49. PubMed ID: 8783577
[No Abstract] [Full Text] [Related]
15. A theory of the etiology and pathogenesis of human cutaneous malignant melanoma.
Holman CD; Armstrong BK; Heenan PJ
J Natl Cancer Inst; 1983 Oct; 71(4):651-6. PubMed ID: 6578359
[No Abstract] [Full Text] [Related]
16. DNA repair gene XRCC3 241Met variant is not associated with risk of cutaneous malignant melanoma.
Duan Z; Shen H; Lee JE; Gershenwald JE; Ross MI; Mansfield PF; Duvic M; Strom SS; Spitz MR; Wei Q
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1142-3. PubMed ID: 12376526
[No Abstract] [Full Text] [Related]
17. Theories regarding the cause of malignant melanoma.
Ariel IM
Surg Gynecol Obstet; 1980 Jun; 150(6):907-17. PubMed ID: 6990527
[No Abstract] [Full Text] [Related]
18. Molecular staging of melanoma.
Shivers S; Alsarraj M; Guiliano R; Jakub J; Pendas S; Reintgen D
Ann Surg Oncol; 2004 Nov; 11(11):953-4. PubMed ID: 15525822
[No Abstract] [Full Text] [Related]
19. Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists.
Shapiro M; Chren MM; Levy RM; Elder DE; LeBoit PE; Mihm MC; Margolis DJ; Gimotty PA; Ming ME
J Cutan Pathol; 2004 Sep; 31(8):523-30. PubMed ID: 15268706
[TBL] [Abstract][Full Text] [Related]
20. Thin cutaneous malignant melanoma and the MIN terminology.
Skov L; Clemmensen O; Baadsgaard O
Lancet; 1997 Nov; 350(9087):1264-5. PubMed ID: 9357402
[No Abstract] [Full Text] [Related]
[Next] [New Search]
